Cargando…
Pharmaceutical Industry Off-label Promotion and Self-regulation: A Document Analysis of Off-label Promotion Rulings by the United Kingdom Prescription Medicines Code of Practice Authority 2003–2012
BACKGROUND: European Union law prohibits companies from marketing drugs off-label. In the United Kingdom—as in some other European countries, but unlike the United States—industry self-regulatory bodies are tasked with supervising compliance with marketing rules. The objectives of this study were to...
Autores principales: | Vilhelmsson, Andreas, Davis, Courtney, Mulinari, Shai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4727894/ https://www.ncbi.nlm.nih.gov/pubmed/26812151 http://dx.doi.org/10.1371/journal.pmed.1001945 |
Ejemplares similares
-
Complaints, Complainants, and Rulings Regarding Drug Promotion in the United Kingdom and Sweden 2004–2012: A Quantitative and Qualitative Study of Pharmaceutical Industry Self-Regulation
por: Zetterqvist, Anna V., et al.
Publicado: (2015) -
Off-Label Promotion, On-Target Sales
por: Fugh-Berman, Adriane, et al.
Publicado: (2008) -
Incidence of unlicensed and off-label prescription in children
por: Langerová, Petra, et al.
Publicado: (2014) -
Pharmaceutical lobbying and pandemic stockpiling of Tamiflu: a qualitative study of arguments and tactics
por: Vilhelmsson, Andreas, et al.
Publicado: (2018) -
Utilisation and Off-Label Prescriptions of Respiratory Drugs in Children
por: Schmiedl, Sven, et al.
Publicado: (2014)